TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ:CGEN) announced today the development of a new discovery engine for the identification of existing drug molecules that are predicted to have important therapeutic indications that are currently not known, and the selection of nine product candidates from the initial use of this engine.
